$259.7 M

XBIT Mkt cap, 10-Jun-2019
XBiotech Net income (Q2, 2019)-5.9 M
XBiotech EBIT (Q2, 2019)-6 M
XBiotech Cash, 30-Jun-201944.9 M

XBiotech Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017FY, 2018

R&D expense

31.3m42.5m26.4m15.7m

General and administrative expense

6.2m10.3m7.6m5.3m

Operating expense total

37.5m52.8m34.1m21.0m

EBIT

(37.5m)(52.8m)(34.1m)(21.0m)

Interest income

49.0k354.0k400.0k

Net Income

(37.5m)(50.7m)(33.1m)(21.1m)

XBiotech Cash Flow

XBiotech Ratios

USDY, 2019

Financial Leverage

1 x

XBiotech Employee Rating

3.029 votes
Culture & Values
3.0
Work/Life Balance
3.4
Senior Management
2.7
Salary & Benefits
2.7
Career Opportunities
2.8
Source